Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiroSearch: impact of medication guidance on satisfaction with mirogabalin in neuropathic pain
jRCTs041230059Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mirogabalin in Neuralgia, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Patient treatment satisfaction. Started Jul 2023; status: completed.
02
Drugs
mirogabalin
03
Conditions
Neuralgia
Beyond the preview
Go deeper on jRCTs041230059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041230059.